As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
Many of the coronavirus vaccines like it cold. Really cold. Sub-zero cold. Why is this the case? And how is the world handling this frigid requirement?
In a new round of tests, the drug company wants to see if booster doses of its vaccine will ramp up defenses against emerging strains of the coronavirus.
The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.
Agency officials said reducing the number of doses creates a potential for harm in patients because "they may assume that they are fully protected when they are not" and may "take unnecessary risks."
The top military official with the federal vaccine effort spoke less than 24 hours after Moderna's COVID-19 vaccine became the second to receive an emergency use authorization from the FDA.
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.
Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.
The power of family history can lead a person to do lot of things. For Howard Berkes, the family tradition of facing crises head-on led him to sign up for experimental testing of a COVID-19 vaccine.
Within hours, U.S. states are expected have in hand their first shipments of Pfizer's newly FDA-authorized COVID-19 vaccine. It marks a new phase in the pandemic, but what's that mean for you?
As FDA emergency use authorization of Pfizer and Moderna vaccines nears, airlines, FedEx and UPS prepare to transport millions of vials of life saving shots.
In the U.S., front-line health care workers are likely first in line to get immunized with a COVID-19 vaccine, once the FDA says yes. But what about the rest of us? Here's what we know so far.
One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.
Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
The Department of Health and Human Services outlined support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.
